PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Supplementation significantly reduced concentrations of aspartate aminotransferase (AST) and alanine transaminase (ALT) compared to placebo, particularly in patients with non-alcoholic fatty liver disease [PMID:34383355].
Administration of 2 to 3 g/d of artichoke leaf extract is associated with decreased serum LDL, total cholesterol, and triglyceride concentrations [PMID:30308247].
Leaf extracts demonstrated protective effects against liver injury induced by diazinon [PMID:31469651], aflatoxin B1 [PMID:36196508, PMID:35909495], and lead toxicity [PMID:23745593].
Hydroethanolic extracts of leaves and flower heads improved hepatic glycogen content and reduced AST and ALT activities in diabetic rats [PMID:37163198].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 26310198 (2015) — Pharmacological Studies of Artichoke Leaf Extract and Their Health Benefits. · Plant foods for human nutrition (Dordrecht, Netherlands)
- 2.PMID: 38542782 (2024) — Functional and Therapeutic Potential of Cynara scolymus in Health Benefits. · Nutrients
- 3.PMID: 38790727 (2024) — Globe Artichoke (Cynara scolymus L.) By-Products in Food Applications: Functional and Biological Properties. · Foods (Basel, Switzerland)
- 4.PMID: 23421105 (2012) — [Artichoke--herbal drug]. · Przeglad lekarski
- 5.PMID: 38474726 (2024) — An Overview of the Versatility of the Parts of the Globe Artichoke (Cynara scolymus L.), Its By-Products and Dietary Supplements.